KR920700202A - 아크릴로일 치환된 피롤 유도체 - Google Patents

아크릴로일 치환된 피롤 유도체

Info

Publication number
KR920700202A
KR920700202A KR1019900702495A KR900702495A KR920700202A KR 920700202 A KR920700202 A KR 920700202A KR 1019900702495 A KR1019900702495 A KR 1019900702495A KR 900702495 A KR900702495 A KR 900702495A KR 920700202 A KR920700202 A KR 920700202A
Authority
KR
South Korea
Prior art keywords
methyl
pyrrole
carboxamido
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019900702495A
Other languages
English (en)
Other versions
KR0170767B1 (ko
Inventor
몬젤리 니콜라
비아솔리 지오반니
카폴롱고 라우라
페쪼니 가브리엘라
Original Assignee
비토리노 페라리오
팜이탈리아 카를로 에르바 에스. 알. 엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비토리노 페라리오, 팜이탈리아 카를로 에르바 에스. 알. 엘. filed Critical 비토리노 페라리오
Publication of KR920700202A publication Critical patent/KR920700202A/ko
Application granted granted Critical
Publication of KR0170767B1 publication Critical patent/KR0170767B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

내용 없음

Description

아크릴로일 치환된 피롤 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 하기 일반식(Ⅰ)의 화합물 및 이의 약제학적으로 허용가능한 염:
    상기식에서, n은 1 내지 5의 정수이고; R1및 R2는 각각 동일하거나 상이하며, 수소, 할로겐, －CN, －NO2, C1－C4알킬 또는 그룹이고; R3는 수소, 할로겐, －CN, －NO2,이며; R4는 각각 독립적으로 수소 또는 C1－C4알킬이고; A는 결합, 그룹또는 그룹 －NH－헤트－CO－(여기에서, 헤트는 포화 또는 불포화 펜타토믹 또는 헥사토믹 헤테로모노사이틀릭 환이다)이며 B는 그룹또는(여기에서 m은 1, 2 또는 3이고, R5는 각각 독립적으로 C1－C4알킬그룹이다)이다.
  2. 제1항에 있어서, n은 3, 4 또는 5이고; A는 결합 또는 그룹이며; B는 그룹이고;R1및 R2는 수소이며; R3는 염소 또는 브롬이고, R4는 메틸인 일반식(Ⅰ)의 화합물 및 이의 약제학적으로 허용가능한 산과의 염.
  3. N－데포밀－N(α－클로로아크릴로일)디스타마아신 A; β－(N－메틸－4－(N－메틸－4－(N－메틸－4－(N-메틸-4(α－클로로－아클릴아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)프로피온아미딘; N－데포밀－N－(α－브로모아크릴로일)디스타마이신 A; β－(N－메틸－4－(N－메틸－4－(N－메틸－4－(N－메틸－4－(α－브로모아크릴－아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)프로피온아미딘; β－(N－메틸－4－(N－메틸－4－(N－메틸－4－N－메틸－4－(N－메틸－4(α－브로모아크릴아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)피롤－2－카복스아미도)프로피온아미딘; N－데포밀－N－(4－(α－브로모아크릴아미도) 벤조일)－디스타마아신 A; 3－(N－메틸－4－(N－메틸－4－4(N－메틸－4－(α－클로로아크릴아미도)피롤－2－카복스아미도)피롤－2－자복스아미도)피롤－2－자복스아미도)피놀－2－자복스아미도프로필－디메틸아민중에서 선택된 화합물 및 이의 약제학적으로 허용가능한 염.
  4. 제1항 내지 3항중 어느 한 항에 있어서, 염이 하이드로클로라이드인 염.
  5. A) 하기 일반식(Ⅱ)의 화합물 또는 이의 염을 일반식(Ⅲ)의 화합물과 반응시켜 일반식(Ⅰ)의 화합물 또는 이의 염을 수득하거나; B)하기 일반식(Ⅳ)의 화합물 또는 이의 염을 하기 일반식(Ⅴ)의 화합물과 반응시켜, A가 그룹또는 －NH－헤트인 일반식(Ⅰ)의 화합물 또는 이의 염을 수득함을 특징으로 하여, 제1항에 따른 일반식(Ⅰ)의 화합물 또는 이의 염을 제조하는 방법.
    상기식에서, R1, R2, R3, R4, A, B, 헤트 및 n은 제1항에서 정의된 것과 같으며; X는 하이드록시 또는 이탈그룹이고; Z은또는 H2N－헤트－CO－ 이다.
  6. 적합한 담체 및/또는 희석제 및 주요 활성물질로서 제1항에 따른 일반식(Ⅰ)의 화합물 또는 이의 약제학적으로 허용가능한 염을 함유하는 약제학적 조성물.
  7. 항종양제로서 유용한 제1항에 따른 화합물(Ⅰ)의 화합물 또는 이의 염.
  8. 항종양제로서 유용한 제6항에 따른 약제학적 조성물.
  9. 항종양제로서 유용한 약제학적 조성물의 제조에 있어서, 제1항에 따른 일반식(Ⅰ)의 화합물 또는 이의 염의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900702495A 1989-03-23 1990-03-22 아크릴로일 치환된 피롤 유도체 Expired - Fee Related KR0170767B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898906709A GB8906709D0 (en) 1989-03-23 1989-03-23 Acryloyl substituted pyrrole derivatives
GB89067094 1989-03-23
GB8906709.4 1989-03-23
PCT/EP1990/000471 WO1990011277A1 (en) 1989-03-23 1990-03-22 Acryloyl substituted pyrrole derivatives

Publications (2)

Publication Number Publication Date
KR920700202A true KR920700202A (ko) 1992-02-19
KR0170767B1 KR0170767B1 (ko) 1999-02-01

Family

ID=10653895

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900702495A Expired - Fee Related KR0170767B1 (ko) 1989-03-23 1990-03-22 아크릴로일 치환된 피롤 유도체

Country Status (21)

Country Link
US (1) US5175182A (ko)
EP (2) EP0416075A1 (ko)
JP (1) JP2986208B2 (ko)
KR (1) KR0170767B1 (ko)
AT (1) ATE98634T1 (ko)
AU (1) AU635733B2 (ko)
CA (1) CA2030519C (ko)
DE (1) DE69005164T2 (ko)
DK (1) DK0388948T3 (ko)
ES (1) ES2062143T3 (ko)
FI (1) FI95463C (ko)
GB (1) GB8906709D0 (ko)
HU (1) HU213507B (ko)
IE (1) IE64654B1 (ko)
IL (1) IL93816A0 (ko)
MY (1) MY106406A (ko)
NZ (1) NZ233015A (ko)
PT (1) PT93552B (ko)
RU (1) RU2094430C1 (ko)
WO (1) WO1990011277A1 (ko)
ZA (1) ZA902221B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247878B (it) * 1991-02-15 1995-01-05 Menarini Farma Ind Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
IT1262921B (it) * 1992-01-10 1996-07-22 Federico Arcamone Agenti antitumorali analoghi di oligopeptidi pirrol-amidinici retroversi processi di preparazione e prodotti farmaceutici che li contengono
IT1271456B (it) * 1993-03-01 1997-05-28 Menarini Farma Ind Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
DE69615814T2 (de) * 1995-09-12 2002-06-06 Kyowa Hakko Kogyo Co., Ltd. Uch-15-verbindungen
US6506906B1 (en) 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
WO1998045284A1 (en) 1996-02-26 1998-10-15 California Institute Of Technology Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
JP2001513759A (ja) 1996-02-26 2001-09-04 カリフォルニア・インスティチュート・オブ・テクノロジー 二本鎖ｄｎａの副溝において結合する改良されたポリアミド
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6555692B1 (en) 1996-02-26 2003-04-29 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
US6559125B1 (en) 2000-01-28 2003-05-06 California Institute Of Technology Polyamide-alkylator conjugates and related products and method
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
US6576612B1 (en) 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives
GB0029004D0 (en) 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
ITTO20010633A1 (it) * 2001-07-02 2003-01-02 Univ Ferrara Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
DE60210329T2 (de) * 2002-01-02 2006-11-30 Nerviano Medical Sciences S.R.L., Nerviano Kombinierte tumortherapie auf der basis von substituierten acryloyl-distamycin-derivaten und protein-kinase (serin/threonin-kinase) inhibitoren
KR20100068083A (ko) * 2008-12-12 2010-06-22 제일모직주식회사 (메트)아크릴레이트 화합물, 감광성 폴리머, 및 레지스트 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA547128A (en) * 1957-10-08 W. Waller Coy Substituted pyrrolecarboxamidopyrroles
US557568A (en) * 1896-04-07 Charles epros
FR86210E (ko) * 1963-04-04 1966-03-23
FR141F (fr) * 1963-07-26 1965-07-08 Farmaceutici Italia Nouveaux dérivés du pyrrol
DE1470284B1 (de) * 1963-07-26 1971-12-16 Farmaceutici Italia Beta-{1-Methyl-4-[1-methyl-4-(1-methyl-4-formylamino-pyrrol-2-carboxamido)-pyrrol-2-carboxamido]-pyrrol-2-carboxamido}-propionamidin sowie dessen Saeureadditionssalze
DE1795539A1 (de) * 1963-07-26 1972-01-13 Farmaceutici Italia Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
NL130086C (ko) * 1964-07-14 1970-06-15
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法
GB8517922D0 (en) * 1985-07-16 1985-08-21 Erba Farmitalia Carboxamido derivatives
SE468642B (sv) * 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents

Also Published As

Publication number Publication date
PT93552A (pt) 1990-11-07
IE901003L (en) 1990-09-23
MY106406A (en) 1995-05-30
US5175182A (en) 1992-12-29
HK1006456A1 (en) 1999-02-26
JPH03504863A (ja) 1991-10-24
ATE98634T1 (de) 1994-01-15
AU635733B2 (en) 1993-04-01
PT93552B (pt) 1997-04-30
DK0388948T3 (da) 1994-01-24
CA2030519A1 (en) 1990-09-24
FI95463C (fi) 1996-02-12
FI95463B (fi) 1995-10-31
HUT54981A (en) 1991-04-29
FI905758A0 (fi) 1990-11-21
CA2030519C (en) 2000-07-11
ZA902221B (en) 1990-12-28
HU213507B (en) 1997-07-28
JP2986208B2 (ja) 1999-12-06
IE64654B1 (en) 1995-08-23
EP0388948B1 (en) 1993-12-15
AU5276190A (en) 1990-10-22
DE69005164D1 (de) 1994-01-27
EP0388948A1 (en) 1990-09-26
WO1990011277A1 (en) 1990-10-04
IL93816A0 (en) 1990-12-23
HU902839D0 (en) 1991-03-28
KR0170767B1 (ko) 1999-02-01
ES2062143T3 (es) 1994-12-16
GB8906709D0 (en) 1989-05-10
NZ233015A (en) 1991-09-25
EP0416075A1 (en) 1991-03-13
DE69005164T2 (de) 1994-03-31
RU2094430C1 (ru) 1997-10-27

Similar Documents

Publication Publication Date Title
CA2098735A1 (en) Novel methylenebisphosphonic acid derivatives
KR870008846A (ko) 8-위치 치환된 퀴놀론카복실산 유도체 및 그의 제조방법
TR199902897T2 (xx) S�v� benz-izo-kuinolin t�revleri.
AU1811988A (en) A process for the preparation of substituted indolin-2-one derivatives
MY123083A (en) Acyclic nucleoside derivatives
CA2306963A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
GB2066812A (en) 5'-acyl-uridine derivatives and processes for the preparation thereof
KR890014523A (ko) 피리미딘유도체, 그것의 제조방법 및 그것을 함유하는 제초조성물
AU641686B2 (en) Benzanilides
KR880009926A (ko) 알킬멜라토닌
KR900009661A (ko) 에르골린 유도체
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
KR910006294A (ko) 피롤로피리미딘, 그의 제법 및 용도
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
KR890002111A (ko) 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용
KR880013929A (ko) 신규 5-메톡시 알킬 암노늄 테트라히드로푸란 및 테트라히드로티오펜
KR910011845A (ko) 2-푸릴피리미딘 유도체의 제조방법
KR870002110A (ko) 구아니디노티아졸 유도체의 제조방법
KR880001659A (ko) 테트라사이클릭 인돌 유도체
IE45889L (en) 4-AMINO-BENZO (b) BICYCLO [3.3.1] NONENE DERIVATIVES,¹ANTI-DEPRESSANTS
KR910014369A (ko) 이미다졸릴 프로필 구아니딘 유도체와 그 제조방법 및 이를 함유하는 약학적 조성물
KR890009896A (ko) 디옥사조신 유도체, 그의 제법 및 그를 함유하는 조성물
KR880007465A (ko) N-(4-피페리딜)벤즈아미드 및 그 염의 제조방법
HUT59399A (en) Process for producing substituted 3-aminosydnone imine derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20050930

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20061017

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20061017

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000